Updates & Impacts: Treating Hematologic Malignancies in 2022
Updates & Impacts: Treating Hematologic Malignancies in 2022 is a one-day regional conference with the goal of disseminating recently-presented data and emerging trends from the American Society of Hematology’s annual meeting and exposition. Presentations from key thought leaders will focus on how scientific advances will impact clinical practice in treating lymphoma, multiple myeloma, acute and chronic leukemias, and myeloproliferative neoplasms. Panel discussions will include perspectives from community physicians. We invite you to join us on February 25 for this engaging educational experience.
Co-Chairs
John P. Leonard, MD
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Senior Associate Dean for Innovation and Initiatives
Executive Vice Chairman, Department of Medicine
Weill Cornell Medicine
New York, New York
Mark Heaney, MD, PhD
Associate Professor of Medicine
Columbia University Irving Medical Center
New York, New York
